Skip to main content
Caplight Logo









EvoEndo

EvoEndo

Private
Grayslake, IllinoisHealthcare & Life Scienceshttps://www.evoendo.com/

Last Round

Series A

Extension

Apr 13, 2023

Total Funding Raised

$18.53M

Company Overview

EvoEndo is a healthtech company that develops a single-use endoscopy system for unsedated transnasal endoscopy procedures for pediatric and adult patients.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

single-use endoscopedisposable endoscopegastroenterology equipmentunsedated endoscopytransnasal endoscopyoffice-based endoscopypediatric endoscopygastroscopemedical devicerazor-and-blade modelendoscopy systemclinical workflow

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EvoEndo Comparables

Compare EvoEndo with similar companies based on industry and business-model similarity.

EvoEndo comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
IQ Endoscopes Limited
82%
Ambu A/S
77%
Cortex, Inc.
74%

EvoEndo Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionApr 13, 2023
GrantOct 24, 2022
Series AApr 19, 2022
SeedJun 3, 2021

Key People

Founding team and executive leadership

Jonathan Hartmann

Chief Executive Officer

Executive Team

Carrie Showalter

Chief Financial Officer

Executive Team

Ryan Hartman

Chief Operating Officer

Executive Team

EvoEndo Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 19, 2022

    $8.4M round led by TLP Investment Partners

EvoEndo Filings

Explore SEC and related filing metadata, where available.

EvoEndo filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about EvoEndo's valuation, stock price, and market status.

Is EvoEndo a public or private company?

EvoEndo is a private company.

What is the current stock price of EvoEndo?

EvoEndo is a private company with no public stock price. No recent secondary market data is available.

How much is EvoEndo worth (valuation)?

Valuation information for EvoEndo is not publicly available.

Can I buy EvoEndo stock?

EvoEndo shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was EvoEndo's last funding round?

EvoEndo's most recent funding round was Series A Extension on April 13, 2023.

Who are the main investors in EvoEndo?

Key investors in EvoEndo include TLP Investment Partners.

Will EvoEndo IPO soon?

No public IPO plans have been announced for EvoEndo.

How can I track EvoEndo secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor EvoEndo's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersGrayslake, Illinois
Employee Range14
Year Founded2017
Last FundingApr 13, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?